Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1976 1
1983 1
1987 3
1988 1
1989 2
1990 2
1991 2
1992 1
1993 1
1995 7
1996 3
1997 3
1998 1
2000 1
2001 2
2003 3
2004 3
2005 3
2007 2
2008 3
2010 1
2011 3
2012 3
2013 1
2014 3
2015 6
2016 9
2017 2
2018 4
2019 3
2020 6
2021 4
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators. Torres VE, et al. N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4. N Engl J Med. 2017. PMID: 29105594 Free article. Clinical Trial.
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC; Conference Participants. Chapman AB, et al. Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18. Kidney Int. 2015. PMID: 25786098 Free PMC article.
Polycystic Kidney Disease.
Ghata J, Cowley BD Jr. Ghata J, et al. Among authors: cowley bd jr. Compr Physiol. 2017 Jun 18;7(3):945-975. doi: 10.1002/cphy.c160018. Compr Physiol. 2017. PMID: 28640449 Review.
Bridging neuronal correlations and dimensionality reduction.
Umakantha A, Morina R, Cowley BR, Snyder AC, Smith MA, Yu BM. Umakantha A, et al. Among authors: cowley br. Neuron. 2021 Sep 1;109(17):2740-2754.e12. doi: 10.1016/j.neuron.2021.06.028. Epub 2021 Jul 21. Neuron. 2021. PMID: 34293295 Free PMC article.
Evaluation of Neurofeedback Learning in Patients with ADHD: A Systematic Review.
Kuznetsova E, Veilahti AVP, Akhundzadeh R, Radev S, Konicar L, Cowley BU. Kuznetsova E, et al. Among authors: cowley bu. Appl Psychophysiol Biofeedback. 2023 Mar;48(1):11-25. doi: 10.1007/s10484-022-09562-2. Epub 2022 Sep 30. Appl Psychophysiol Biofeedback. 2023. PMID: 36178643 Free PMC article. Review.
94 results